Predictive Technology Group, Inc. (PRED) Announces Notice of US Patent Allowance for Method for Treating Patients with Genetic Spinal Deformities and Syndromes

Allowance Strengthens Commercialization Strategy of Company s Proprietary Diagnostics and Therapeutics SALT LAKE CITY, UT, PRED, (Marketwired December 16, 2016) Predictive Technology Group, Inc. (OTC PINK: PRED), a life sciences technology holding company, announced today that the United States Patent and Trademark Office (USPTO) has allowed a fundamental patent application US20160296671 -that covers the practice of administering ANY spine deformation therapeutics to a patient having a spine deformation altered risk associated biomarker. We are pleased to see this latest
http://bit.ly/2gJTlGx